United States · Wires & real time · Business Wire
Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock
Blackstone Life Sciences (“BXLS”) today announced a $455 million collaboration with Boston Scientific Corporation (NYSE: BSX) to co-fund the development of ...
Read the full article on Business Wire Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.businesswire.com)
